Intended for healthcare professionals

  1. Research
  2. Predicting...
  3. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Research

Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2

BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39609.449676.25 (Published 26 June 2008) Cite this as: BMJ 2008;336:1475

Related articles

See more

Cited by...

  • Cardiovascular risk estimation and statin adherence: a historical cohort study protocol
  • Kolmogorov-Arnold Network for Atherosclerotic Cardiovascular Disease Risk Prediction
  • Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking study
  • Appraising Cardiovascular 10-yr Risk Prediction Scores: A Rapid Systematic Review
  • Fair machine learning models for disease prediction: In-depth interviews with key health experts
  • Trends and inequalities in statin use for the primary and secondary prevention of cardiovascular disease between 2009 and 2021 in England
  • Mechanistic genotype-phenotype translation using hierarchical transformers
  • Refined selection of individuals for preventive cardiovascular disease treatment with a Transformer-based risk model
  • Age and sex specific thresholds for risk stratification of cardiovascular disease and clinical decision making: prospective open cohort study
  • Assessing the effectiveness of "BETTER Women", a community-based, primary care-linked peer health coaching programme for chronic disease prevention: protocol for a pragmatic, wait-list controlled, type 1 hybrid effectiveness-implementation trial
  • A self-report tool for identification of individuals with coronary atherosclerosis - The Swedish CArdioPulmonary BioImage Study
  • Evaluation of clinical prediction models (part 1): from development to external validation
  • Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study
  • MSGene: Derivation and validation of a multistate model for lifetime risk of coronary artery disease using genetic risk and the electronic health record
  • Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
  • Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study
  • Comparing the effectiveness of the NHS Health Check and the Polypill Prevention Programmes in the primary prevention of heart attacks and strokes
  • UK research data resources based on primary care electronic health records: review and summary for potential users
  • Absolute cardiovascular risk assessment by Australian early-career general practitioners: a cross-sectional study
  • Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
  • Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKI
  • First-line immunosuppression in neuromuscular diseases
  • Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort
  • Evaluating the clinical effectiveness of the NHS Health Check programme: a prospective analysis in the Genetics and Vascular Health Check (GENVASC) study
  • First-line immunosuppression in neuromuscular diseases
  • Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKI
  • Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data
  • Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study
  • Identification and analysis of individuals who deviate from their genetically-predicted phenotype
  • Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data
  • Cancer history as a predictor in cardiovascular risk scores: a primary care cohort study
  • Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice
  • Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study
  • Comparing antibiotic prescribing between clinicians in UK primary care: an analysis in a cohort study of eight different measures of antibiotic prescribing
  • Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study
  • Regression discontinuity design to evaluate the effect of statins on myocardial infarction in electronic health records
  • Inter-arm blood pressure difference and cardiovascular risk estimation in primary care: a pilot study
  • IVIg-exposure and thromboembolic event risk: findings from the UK Biobank
  • An independent external validation of the QRISK3 cardiovascular risk prediction model applied to UK Biobank participants
  • Polygenic Risk Score Improves the Accuracy of a Clinical Risk Score for Coronary Artery Disease
  • Endorsement of the TRIPOD statement and the reporting of studies developing contrast-induced nephropathy prediction models for the coronary angiography/percutaneous coronary intervention population: a cross-sectional study
  • Cardiovascular Risk Models in Chronic Kidney Disease: A Systematic Review and External Validation of Models
  • Predicting asthma-related crisis events using routine electronic healthcare data: a quantitative database analysis study
  • Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypes
  • Increasing uptake of NHS Health Checks: a randomised controlled trial using GP computer prompts
  • Relationship between loneliness, social isolation and modifiable risk factors for cardiovascular disease: a latent class analysis
  • Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus
  • Do statins reduce mortality in older people? Findings from a longitudinal study using primary care records
  • Uncovering undiagnosed liver disease: prevalence and opportunity for intervention in a population attending colonoscopy
  • Clustering of physical health multimorbidity in 68,392 people with severe mental illness and matched comparators: a lifetime prevalence analysis of United Kingdom primary care data
  • Underlying cardiovascular risk and major adverse cardiovascular events after acute respiratory infection: a population-based cohort study of over 4.2 million individuals in England, 2008-2018
  • Arm Based on LEg blood pressures (ABLE-BP): can systolic leg blood pressure measurements predict systolic brachial blood pressure? Protocol for an individual participant data meta-analysis from the INTERPRESS-IPD Collaboration
  • Factors predicting statin prescribing for primary prevention: a historical cohort study
  • Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study
  • Mortality in COVID-19 amongst women on Hormone Replacement Therapy or Combined Oral Contraception: A cohort study
  • Chronic acid-suppressant use and risk of Oesophageal cancer: protocol for a longitudinal study using a large population based cohort
  • Adoption of clinical risk prediction tools is limited by a lack of integration with electronic health records
  • Absolute cardiovascular disease risk score and pharmacotherapy at the time of admission in patients presenting with acute coronary syndrome due to coronary artery disease in a single Australian tertiary centre: a cross-sectional study
  • Cardiovascular risk prediction tools made relevant for GPs and patients
  • Educational inequalities in statin treatment for preventing cardiovascular disease: cross-sectional analysis of UK Biobank
  • Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
  • GPs familiarity with and use of cardiovascular clinical prediction rules: a UK survey study
  • Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care
  • Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care setting
  • DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study
  • Fidelity of the delivery of NHS Health Checks in general practice: an observational study
  • Comparison of carotid artery ultrasound and Framingham risk score for discriminating coronary artery disease in patients with psoriatic arthritis
  • Temporal Trend in Young-Onset Type 2 Diabetes--Macrovascular and Mortality Risk: Study of U.K. Primary Care Electronic Medical Records
  • Longitudinal associations between loneliness, social isolation and cardiovascular events
  • Diurnal patterns of sedentary time in rheumatoid arthritis: associations with cardiovascular disease risk
  • Predictive Utility of Cardiovascular Risk Prediction Algorithms in Inflammatory Rheumatic Diseases: A Systematic Review
  • Cardiovascular risk profiles and the uptake of the NHS Healthcheck programme in male prisoners in six UK prisons: an observational cross-sectional survey
Back to top